Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$208M |
| 2 |
Lowe's Companies
LOW
|
+$198M |
| 3 |
American Tower
AMT
|
+$161M |
| 4 |
Lennar Class A
LEN
|
+$150M |
| 5 |
British American Tobacco
BTI
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$208M |
| 2 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$177M |
| 3 |
Crown Castle
CCI
|
+$168M |
| 4 |
Walmart Inc
WMT
|
+$167M |
| 5 |
Entergy
ETR
|
+$157M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.75% |
| 2 | Technology | 13.18% |
| 3 | Healthcare | 11.51% |
| 4 | Industrials | 10.45% |
| 5 | Consumer Discretionary | 9.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2076
Greif Class B
GEF.B
$4.11B
| $2.38M | ﹤0.01% |
37,018
+30,306
| +452% | +$1.85M |
|
2077
Entravision Communication
EVC
$737M
| $2.38M | ﹤0.01% |
416,644
+182,115
| +78% | +$1.1M |
|
2078
1st Source
SRCE
$2.08B
| $2.37M | ﹤0.01% |
+46,672
| New | +$2.23M |
|
2079
AMERISAFE
AMSF
$487M
| $2.37M | ﹤0.01% |
40,687
+11,676
| +40% | +$655K |
|
|
ITCI
2080
PUT
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $2.37M | ﹤0.01% |
+150,000
| New | +$2.2M |
|
|
KE
2081
Kimball Electronics
KE
$574M
| $2.36M | ﹤0.01% |
109,187
+24,224
| +29% | +$468K |
|
|
EA
2082
CALL
DELISTED
Electronic Arts
EA
| $2.36M | ﹤0.01% |
+20,000
| New | +$2.32M |
|
2083
Grupo Cibest SA
CIB
$23.9B
| $2.36M | ﹤0.01% |
+51,510
| New | +$2.32M |
|
|
JWN
2084
PUT
DELISTED
Nordstrom
JWN
| $2.36M | ﹤0.01% |
+50,000
| New | +$2.32M |
|
|
ORBC
2085
DELISTED
ORBCOMM, Inc.
ORBC
| $2.36M | ﹤0.01% |
225,199
+78,044
| +53% | +$863K |
|
|
DX
2086
Dynex Capital
DX
$3.2B
| $2.35M | ﹤0.01% |
107,690
+66,943
| +164% | +$1.42M |
|
2087
Enova International
ENVA
$5.89B
| $2.35M | ﹤0.01% |
174,406
+146,482
| +525% | +$1.99M |
|
2088
Stock Yards Bancorp
SYBT
$2.48B
| $2.35M | ﹤0.01% |
61,725
+38,846
| +170% | +$1.4M |
|
2089
Lamar Advertising Co
LAMR
$15.4B
| $2.35M | ﹤0.01% |
34,221
-34,134
| -50% | -$2.31M |
|
|
COTV
2090
DELISTED
Cotiviti Holdings, Inc.
COTV
| $2.35M | ﹤0.01% |
+65,186
| New | +$2.45M |
|
2091
PUT
Jack in the Box
JACK
$316M
| $2.34M | ﹤0.01% |
23,000
-27,000
| -54% | -$2.58M |
|
2092
WPP
WPP
$5.58B
| $2.33M | ﹤0.01% |
25,127
-55,922
| -69% | -$5.48M |
|
2093
Acadia Pharmaceuticals
ACAD
$5.1B
| $2.32M | ﹤0.01% |
61,669
-527,253
| -90% | -$17.2M |
|
2094
Copa Holdings
CPA
$5.99B
| $2.32M | ﹤0.01% |
18,614
-16,598
| -47% | -$2.1M |
|
2095
CALL
Encompass Health
EHC
$11.9B
| $2.32M | ﹤0.01% |
+62,850
| New | +$2.24M |
|
2096
Vanguard Morningstar Mid-Cap ETF
VO
$110B
| $2.32M | ﹤0.01% |
63,072
+23,044
| +58% | +$831K |
|
2097
Rayonier Advanced Materials
RYAM
$569M
| $2.31M | ﹤0.01% |
168,625
-242,386
| -59% | -$3.45M |
|
|
MOFG
2098
DELISTED
MidWestOne Financial Group
MOFG
| $2.31M | ﹤0.01% |
68,396
+43,416
| +174% | +$1.47M |
|
2099
Assured Guaranty
AGO
$3.34B
| $2.31M | ﹤0.01% |
61,072
+886
| +1% | +$37.9K |
|
|
VRN
2100
DELISTED
Veren
VRN
| $2.29M | ﹤0.01% |
285,096
-13,909
| -5% | -$102K |
|
Similar funds
Israel Englander's Q3 2017 Portfolio in Review
As of Q3 2017, Israel Englander held 4,198 positions worth $65.6B, up 17% from $56.1B the previous quarter. Its ten largest holdings account for 7.8% of the portfolio.
Israel Englander deployed $6.37B of net new capital in Q3 2017, opening 794 new positions and adding to 1,441 existing holdings. Its largest new stake was Northern Trust: 1,591,041 shares worth $146M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Gilead Sciences, an estimated $208M trimmed.
- Israel Englander's largest Q3 2017 buy was Northern Trust: 1,591,041 shares worth $146M.
- Israel Englander added most to Salesforce in Q3 2017, an estimated $208M increase.
- Israel Englander's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $208M.
- Israel Englander fully exited CONCHO RESOURCES INC. in Q3 2017, selling an estimated $177M.
- Israel Englander's ten largest holdings make up 7.8% of its $65.6B portfolio in Q3 2017.
- Israel Englander opened 794 new positions and closed 737 in Q3 2017.
- Israel Englander's portfolio value rose 17% quarter-over-quarter to $65.6B.
Based on Millennium Management's 13F filing for Q3 2017, filed 14 Nov 2017.